Co-Diagnostics Announces 1-for-25 Reverse Stock Split Effective November 24
Co-Diagnostics (CODX) has announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock. The corporate action is scheduled to take effect on November 24. The company stated that the primary objective of this reverse split is to enable Co-Diagnostics to maintain compliance with exchange listing requirements. Such actions are typically taken by companies to increase their per-share price to meet minimum valuation standards set by major stock exchanges.

Tickers: $CODX
Topics: reverse stock split share consolidation
Read the full article at Seeking Alpha
Part of the story Cyabra Announces 30-for-1 Reverse Stock Split Effective November 23 (6 articles)